Cover Image

CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease

CD44 is a transmembrane protein that transduces extracellular stimuli to immune response. Neuroinflammation is a causative factor in neurodegenerative diseases, such as Parkinson's disease (PD). Owing to its role in inflammation, this study investigated whether CD44 is involved in the pathologi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuejun Wang (Author), Li Li (Author), Yuting Wu (Author), Shouping Zhang (Author), Qianqian Ju (Author), Yinuo Yang (Author), Yan Jin (Author), Hui Shi (Author), Cheng Sun (Author)
Format:	Book
Published:	Elsevier, 2022-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
by: Young Cheul Chung, et al.
Published: (2013)

Corynoxine Protects Dopaminergic Neurons Through Inducing Autophagy and Diminishing Neuroinflammation in Rotenone-Induced Animal Models of Parkinson's Disease
by: Leilei Chen, et al.
Published: (2021)

Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
by: Tomás González-Hernández, et al.
Published: (2010)

Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's disease
by: Colleen S. Stein, et al.
Published: (2022)

Hydralazine represses Fpn ubiquitination to rescue injured neurons via competitive binding to UBA52
by: Shengyou Li, et al.
Published: (2024)

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson's Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019)

Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson's disease
by: Yi Zhao, et al.
Published: (2018)

Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease Models
by: Matthew L. Neal, et al.
Published: (2023)

Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson's Disease
by: Ping Gan, et al.
Published: (2020)

Non-Dopaminergic Systems in Parkinson's Disease
Published: (2020)

Vitexin protects dopaminergic neurons in MPTP-induced Parkinson’s disease through PI3K/Akt signaling pathway
by: Hu M, et al.
Published: (2018)

Echinacoside Protects Dopaminergic Neurons Through Regulating IL-6/JAK2/STAT3 Pathway in Parkinson's Disease Model
by: Xueping Yang, et al.
Published: (2022)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
by: Sara Redenšek, et al.
Published: (2019)

Sequential loss of LC noradrenergic and dopaminergic neurons results in a correlation of dopaminergic neuronal number to striatal dopamine concentration
by: Patricia eSzot, et al.
Published: (2012)

Parkinson's disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022)

Editorial: Non-Dopaminergic Systems in Parkinson's Disease
by: Cristina Miguelez, et al.
Published: (2020)

Molecular Programming of Mesodiencephalic Dopaminergic Neuronal Subsets
by: Marten P. Smidt
Published: (2017)

Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP
by: Juan M. Viveros-Paredes, et al.
Published: (2017)

Spatial and temporal distribution of dopaminergic neurons during development in zebrafish
by: Yuchen Du, et al.
Published: (2016)

PARKINSON'S DISEASE: ANIMAL MODELS AND DOPAMINERGIC CELL VULNERABILITY
by: Javier eBlesa, et al.
Published: (2014)

ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis
by: Kun Li, et al.
Published: (2023)

Application of the Physical Disector Principle for Quantification of Dopaminergic Neuronal Loss in a Rat 6-Hydroxydopamine Nigral Lesion Model of Parkinson's Disease
by: Katrine Fabricius, et al.
Published: (2017)

Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update
by: Lars eBrichta, et al.
Published: (2014)

Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease
by: Yue Dong, et al.
Published: (2018)

Differentiation of adult human mesenchymal stem cells into dopaminergic neurons
by: Marjan Khademizadeh, et al.
Published: (2019)

Caffeine reduces deficits in mechanosensation and locomotion induced by L-DOPA and protects dopaminergic neurons in a transgenic Caenorhabditis elegans model of Parkinson's disease
by: Rafael Vincent M. Manalo, et al.
Published: (2020)

Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
by: Gul-, et al.
Published: (2021)

Synergic action of L-acetylcarnitine and L-methylfolate in Mouse Models of Stress-Related Disorders and Human iPSC-Derived Dopaminergic Neurons
by: Rosamaria Orlando, et al.
Published: (2022)

Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: An immunohistochemical study
by: Pournima Y Godge, et al.
Published: (2011)

O-Cyclic Phytosphingosine-1-Phosphate Protects against Motor Dysfunctions and Glial Cell Mediated Neuroinflammation in the Parkinson's Disease Mouse Models
by: Hyeon Jin Lee, et al.
Published: (2022)

Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells
by: Samuela Cataldi, et al.
Published: (2017)

Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons
by: Damien Meng-Kiat Leow, et al.
Published: (2024)

Prenatal Exposure to Gabapentin Alters the Development of Ventral Midbrain Dopaminergic Neurons
by: Walaa F. Alsanie, et al.
Published: (2022)

CALBINDIN CONTENT AND DIFFERENTIAL VULNERABILITY OF MIDBRAIN EFFERENT DOPAMINERGIC NEURONS IN MACAQUES
by: Iria G Dopeso-Reyes, et al.
Published: (2014)

Pharmacological Transdifferentiation of Human Nasal Olfactory Stem Cells into Dopaminergic Neurons
by: Audrey Chabrat, et al.
Published: (2019)

<i>Rumex japonicus</i> Houtt. Protects Dopaminergic Neurons by Regulating Mitochondrial Function and Gut-Brain Axis in In Vitro and In Vivo Models of Parkinson's Disease
by: Hee-Young Kim, et al.
Published: (2022)

Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45
by: Xianghe Song, et al.
Published: (2016)

Long-Term Effects of Maternal Deprivation on the Volume of Dopaminergic Nuclei and Number of Dopaminergic Neurons in Substantia Nigra and Ventral Tegmental Area in Rats
by: Slobodan Kapor, et al.
Published: (2020)

Alpha6-Containing Nicotinic Acetylcholine Receptors Mediate Nicotine-Induced Structural Plasticity in Mouse and Human iPSC-Derived Dopaminergic Neurons
by: Ginetta Collo, et al.
Published: (2018)

Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism
by: Song Ju-Xian, et al.
Published: (2012)